Neurological

A large population-based study is suggesting some diabetes drugs may also prevent the onset of Parkinson’s disease. Along with prior research, these findings validate a Phase 3 human trial set to test a specific diabetes drug in Parkinson’s patients.

Researchers have discovered a new kind of immune cell with the ability to not only prevent the progressive neurological degeneration associated with diseases such as multiple sclerosis and ALS, but which may even regenerate and repair damaged cells.

A new study is shedding light on the link between autism and gut microbiome impairments. The research reveals a potential mechanism by which altered gut bacteria populations can lead to abnormal microbial detoxification and mitochondrial dysfunction.

An experimental drug has been shown to slow the progression and prolong survival of patients suffering from the neurodegenerative disease ALS. With Phase 2 human trials complete, the company developing the treatment is working to accelerate its approval.

Tinnitus is an aggravating disorder, causing sufferers to constantly hear a ringing in their ears. A new system could help, though, by simultaneously zapping their tongue and delivering sounds to their ears.

Stem cells could help treat a variety of diseases. A new study has found that transplanting neurons grown from stem cells into the brains of mice with Parkinson’s disease repaired the damaged brain circuits, improving the animals’ motor skills.

Preliminary research has discovered several blood-based biomarkers which can specifically indicate stroke damage to brain tissue. The goal of the research is to develop a simple blood test to rapidly detect whether a patient is suffering a minor stroke.

A new article from a team of neuroscientists is warning a future ‘silent wave’ of neurodegenerative disease may be spawned by the COVID-19 pandemic. The researchers suggest the SARS-CoV-2 virus can increase a person’s risk of developing Parkinson’s disease.

A study has homed in on the brain circuit responsible for stress-induced insomnia. The research suggests this same circuit is responsible for stress-related immune system dysfunction, pointing to a close relationship between stress, insomnia and weakened immunity.

A new study, led by researchers from University College London, is offering some of the first robust evidence showing how CBD, a key compound in cannabis, increases cerebral blood flow in memory processing regions of the brain such as the hippocampus.

Scientists investigating Alzheimer’s treatments at the Salk Institute have uncovered some key mechanisms that enable an experimental drug to reverse memory loss in mouse models of the disease, offering new targets for researchers in the field.

Scientists in Australia have made an exciting breakthrough in Alzheimer’s research, demonstrating what they describe as the first gene-therapy-based approach for treating advanced forms of the disease.